Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Appointed director
Inv. presentation
CC transcript
Asset disposition
Cyclacel Pharmaceuticals, Inc. (CYCC) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/16/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
12/21/2020 3 SCHWARTZ BRIAN (Director) has filed a Form 3 on Cyclacel Pharmaceuticals, Inc.
11/12/2020 3 Walker Karin L (Director) has filed a Form 3 on Cyclacel Pharmaceuticals, Inc.
10/28/2020 3 Kirschbaum Mark (Chief Medical Officer) has filed a Form 3 on Cyclacel Pharmaceuticals, Inc.
09/10/2018 3 Spiegel Robert J. (Director) has filed a Form 3 on Cyclacel Pharmaceuticals, Inc.
02/27/2017 3 Form 3 - Initial statement of beneficial ownership of securities
05/27/2011 3 Hradsky Gregory T. (Director) has filed a Form 3 on Cyclacel Pharmaceuticals, Inc.
05/27/2011 3 Sems Lloyd (Director) has filed a Form 3 on Cyclacel Pharmaceuticals, Inc.
10/13/2010 3 MARXE AUSTIN W & GREENHOUSE DAVID M (10% Owner) has filed a Form 3 on Cyclacel Pharmaceuticals, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy